NPS Pharmaceuticals (NPSP)
NPS Pharmaceuticals Historical Price Data
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 30, 2012 | 8.04 | 8.08 | 7.83 | 7.93 | 931808 |
| May 29, 2012 | 7.77 | 8.19 | 7.77 | 8.10 | 1077405 |
| May 25, 2012 | 7.81 | 7.81 | 7.48 | 7.59 | 783245 |
| May 24, 2012 | 7.91 | 8.15 | 7.75 | 7.85 | 559775 |
| May 23, 2012 | 7.74 | 7.95 | 7.56 | 7.91 | 636853 |
| May 22, 2012 | 7.79 | 7.93 | 7.65 | 7.82 | 895106 |
| May 21, 2012 | 7.15 | 7.82 | 7.15 | 7.82 | 1378959 |
| May 18, 2012 | 6.92 | 7.27 | 6.92 | 7.13 | 883905 |
| May 17, 2012 | 7.33 | 7.39 | 6.91 | 6.93 | 785780 |
| May 16, 2012 | 7.51 | 7.62 | 7.27 | 7.32 | 677745 |
| May 15, 2012 | 7.14 | 7.54 | 7.13 | 7.47 | 734288 |
| May 14, 2012 | 6.95 | 7.14 | 6.93 | 7.13 | 428486 |
| May 11, 2012 | 7.01 | 7.075 | 6.92 | 7.01 | 806965 |
| May 10, 2012 | 7.05 | 7.23 | 6.94 | 7.07 | 487857 |
| May 9, 2012 | 6.97 | 7.04 | 6.89 | 6.99 | 267163 |
| May 8, 2012 | 6.91 | 7.10 | 6.76 | 7.07 | 683860 |
| May 7, 2012 | 7.16 | 7.30 | 6.93 | 6.99 | 683064 |
| May 4, 2012 | 7.00 | 7.22 | 6.71 | 7.11 | 984741 |
| May 3, 2012 | 7.16 | 7.34 | 7.05 | 7.16 | 486088 |
| May 2, 2012 | 7.14 | 7.24 | 7.02 | 7.19 | 292578 |
| May 1, 2012 | 7.15 | 7.34 | 7.06 | 7.18 | 539416 |
| April 30, 2012 | 7.35 | 7.40 | 7.00 | 7.16 | 554442 |
| April 27, 2012 | 7.19 | 7.35 | 7.07 | 7.34 | 384937 |
| April 26, 2012 | 7.06 | 7.195 | 7.00 | 7.18 | 342387 |
| April 25, 2012 | 7.01 | 7.14 | 6.99 | 7.08 | 575019 |
| April 24, 2012 | 6.62 | 6.98 | 6.62 | 6.95 | 636760 |
| April 23, 2012 | 6.56 | 6.68 | 6.481 | 6.63 | 372921 |
| April 20, 2012 | 6.61 | 6.79 | 6.51 | 6.65 | 336981 |
| April 19, 2012 | 6.54 | 6.77 | 6.49 | 6.51 | 400715 |
| April 18, 2012 | 6.56 | 6.66 | 6.50 | 6.51 | 319238 |
| April 17, 2012 | 6.52 | 6.76 | 6.52 | 6.60 | 420389 |
| April 16, 2012 | 6.52 | 6.60 | 6.36 | 6.50 | 262545 |
| April 13, 2012 | 6.62 | 6.63 | 6.428 | 6.50 | 358642 |
| April 12, 2012 | 6.50 | 6.70 | 6.50 | 6.65 | 272865 |
| April 11, 2012 | 6.46 | 6.53 | 6.395 | 6.50 | 543468 |
| April 10, 2012 | 6.66 | 6.73 | 6.32 | 6.37 | 688476 |
| April 9, 2012 | 6.74 | 6.91 | 6.65 | 6.65 | 436573 |
| April 5, 2012 | 6.89 | 6.96 | 6.79 | 6.85 | 300025 |
| April 4, 2012 | 6.91 | 6.98 | 6.77 | 6.85 | 461654 |
| April 3, 2012 | 6.99 | 7.12 | 6.92 | 6.97 | 336472 |
| April 2, 2012 | 6.80 | 7.00 | 6.78 | 6.99 | 433863 |
| March 30, 2012 | 6.98 | 6.98 | 6.809 | 6.84 | 359386 |
| March 29, 2012 | 6.89 | 7.02 | 6.878 | 6.91 | 323671 |
| March 28, 2012 | 6.97 | 7.04 | 6.80 | 6.96 | 555992 |
| March 27, 2012 | 6.94 | 7.03 | 6.935 | 6.96 | 300519 |
| March 26, 2012 | 6.72 | 6.94 | 6.72 | 6.91 | 385505 |
| March 23, 2012 | 6.50 | 6.69 | 6.48 | 6.65 | 312646 |
| March 22, 2012 | 6.50 | 6.53 | 6.36 | 6.43 | 485340 |
| March 21, 2012 | 6.66 | 6.709 | 6.48 | 6.50 | 854574 |
| March 20, 2012 | 6.71 | 6.71 | 6.71 | 6.71 | 0.00 |
NPSP News
NPS Pharmaceuticals to Present at Jefferies Global Healthcare Conference
May 29, 4:10PM Business Wire
May 29, 4:10PM Business Wire
RT @TheEquitiesRoom: EBR: Watchlist/worksheet/4 Trading Ideas: $DECK $CRR $NPSP $LOW $V http://stks.co/3wzM < thanks for sharing
about 8 days ago by 1nvestor
about 8 days ago by 1nvestor
$NPSP Close at highs, nice volume too. Can't figure out why this isn't getting more attention.
about 9 days ago by Random_Walk
about 9 days ago by Random_Walk
$NPSP Nice rebound today after yesterday's selloff. Good volume for a change.
about 13 days ago by Random_Walk
about 13 days ago by Random_Walk
$NPSP http://stks.co/3pss Golden Cross, 50MA cross above the 200MA, breakingout the $7.39 resistance, positive momentum
about 16 days ago by gantosj
about 16 days ago by gantosj
ThinkEquity, Canacord, S&P, Needham all have retiterated buy ratings on $NPSP in last week. Very undervalued considering potential here.
about 24 days ago by Random_Walk
about 24 days ago by Random_Walk
$NPSP 200 Day SMA Cross - Price crossed above 200 day SMA (6.8493). Confirmed by volume.
about 27 days ago by TradeIdeasQuant
about 27 days ago by TradeIdeasQuant
$NPSP 200 Day SMA Cross - Price crossed below 200 day SMA (6.8493). Confirmed by volume.
about 27 days ago by TradeIdeasQuant
about 27 days ago by TradeIdeasQuant
Needham & Company Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); Awaiting Date for Gattex FDA AdCom Meeting
May 04, 9:25AM Street Insider
May 04, 9:25AM Street Insider
Listen to $NPSP Q1 2012 earnings call - live at 05:00 PM, ondemand after - http://stks.co/3f5z
about 27 days ago by earningscast
about 27 days ago by earningscast
$NPSP No love for $NPSP? Nice breakout today, albeit on low volume. Long from 7.10. Holding. http://chart.ly/2f5qte9
about 33 days ago by Random_Walk
about 33 days ago by Random_Walk
$NPSP http://stks.co/3YQG breaking out the channel testing the upper line and bouncing back, looks good with positive momentum
about 34 days ago by gantosj
about 34 days ago by gantosj
$NPSP Volume perking up. Upcoming catalyst. Approaching breakout. Keep an eye on $NPSP.
about 36 days ago by Random_Walk
about 36 days ago by Random_Walk
$NPSP http://stks.co/3Ogl Trading in a horizontal channel, Bollinger band in a Volatility Squeeze, near term catalyst
about 43 days ago by gantosj
about 43 days ago by gantosj
$NPSP http://stks.co/3LuR consolidating with a move over 7 targetting 7.83, under 6.38 targets 5.50
about 46 days ago by harmongreg
about 46 days ago by harmongreg
$NPSP filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/3KmH
about 48 days ago by MarketBrief
about 48 days ago by MarketBrief
NPS Pharmaceuticals to Present at Barclays Capital Global Healthcare Conference
Mar 07, 4:10PM Business Wire
Mar 07, 4:10PM Business Wire
NPS Pharmaceuticals Appoints Georges Gemayel, Ph.D., to Board of Directors
Feb 29, 8:10AM Business Wire
Feb 29, 8:10AM Business Wire
NPS Pharmaceuticals Reports 2011 Year-End Financial Results and 2012 Cash Burn Guidance
Feb 15, 4:30PM Business Wire
Feb 15, 4:30PM Business Wire
NPS Pharmaceuticals Announces FDA Acceptance of New Drug Application for GATTEX
Jan 31, 8:04AM Benzinga
Jan 31, 8:04AM Benzinga
NPS Pharma (NPSP) announces FDA acceptance of NDA for Gattex(R) in adult SBS
Jan 31, 8:04AM Street Insider
Jan 31, 8:04AM Street Insider
Needham & Company Reiterates a 'Buy' on NPS Pharmaceuticals (NPSP); Shares Undervalued
Jan 06, 10:29AM Street Insider
Jan 06, 10:29AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| NPSP | 7.93 | -0.17 | -2.10% | 697.49M |
| NPM | 15.24 | +0.03 | +0.20% | |
| NPK | 66.00 | -0.43 | -0.65% | 457.04M |
| NNBR | 7.68 | -0.39 | -4.83% | 136.79M |
| NNA | 2.585 | -0.01 | -0.19% | 104.95M |
| NMT | 15.12 | -0.11 | -0.71% | |
| NMRX | 8.92 | -0.06 | -0.67% | 136.14M |
| NMR | 3.27 | -0.05 | -1.51% | 12.16B |
| NMM | 13.98 | -0.37 | -2.58% | 672.87M |
| NMD | 12.32 | +0.01 | +0.08% |